← Back to Clinical Trials
Recruiting NCT06174701

NCT06174701 Building Resilience for Surgical Recovery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06174701
Status Recruiting
Phase
Sponsor The University of Texas Health Science Center, Houston
Condition Psychosocial Functioning
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-06-04
Primary Completion 2025-06-04

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Problem Solving Therapy (PST)Enhanced Usual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2024-06-04 with a primary completion date of 2025-06-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test problem solving therapy (PST) in older adults who are undergoing major surgery. The main question it aims to answer is: What is the feasibility and acceptability of delivering PST to older surgical patients with depressive symptoms or report lacking social support in the pre-operative and post-operative setting?

Eligibility Criteria

Inclusion criteria: * ≥ 65 years of age on the day of surgery * Scheduled major surgery with an anticipated hospital stay of 3+ days. Major operations include: orthopedic, thoracic or abdominal, cardiac procedures * Depressive symptoms - Patient Health Questionnaire (PHQ-9) screening with a score of 5+, 5-9 being subclinical depression and scores up to 27 indicating increasing depression. If the score is 5-9, we need to have at least one of these items included: "at least one of the endorsed items needs to be depressed mood or diminished activities" (questions #1 and #2) Exclusion criteria: * Those with severe cognitive impairment - Short Portable Mental Status Questionnaire (SPMSQ) screening with a score of 5+ errors, 5-8 being moderate to severe cognitive impairment * Unable to read, speak, and understand English * Current alcohol or other substance abuse (scoring 2+ on CAGE questionnaire or answering yes to "Do you currently use any non-prescription drugs or substances?") * Life expectancy is 6 months or less

Contact & Investigator

Central Contact

Jude des Bordes, MBChB, MPH, DrPH, CPH

✉ Jude.K.desBordes@uth.tmc.edu

📞 713-500-4434

Principal Investigator

Victoria Tang, MD, MAS

PRINCIPAL INVESTIGATOR

The University of Texas Health Science Center, Houston

Frequently Asked Questions

Who can join the NCT06174701 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Psychosocial Functioning. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06174701 currently recruiting?

Yes, NCT06174701 is actively recruiting participants. Contact the research team at Jude.K.desBordes@uth.tmc.edu for enrollment information.

Where is the NCT06174701 trial being conducted?

This trial is being conducted at San Francisco, United States.

Who is sponsoring the NCT06174701 clinical trial?

NCT06174701 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Victoria Tang, MD, MAS at The University of Texas Health Science Center, Houston. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology